Visiopharm and Integrated Systems Engineering have agreed to comarket their products to researchers using tissue microarrays.
Integrated Systems Engineering, or ISENET, is a Milan-based company that offers a menu of tissue microarraying instruments called Galileo TMA CK. Visiopharm is a Hørsholm, Denmark-based firm that provides software for quantitative digital pathology. Visiopharm sells an analysis tool called Arrayimager that can produce a report based on data obtained from Galileo TMA CK systems and manage data, allowing users to search results based on donor identity, specific biomarkers, and other results.
Pasquale De Blasio, CEO of ISENET, said in a statement that the two firms aim to "provide the research and diagnostic communities with a TMA solution focused on quality, data integrity and results."
Both European companies maintain distributors in most major regional markets. Visiopharm has a partnership with Olympus to distribute Arrayimager in North and South America and Asia. ISENET relies on a number of distributors to reach customers in different European countries and also sells its systems direct worldwide from its headquarters in Italy.
Further details of the partnership were not discussed.